Central angiotensin II has catabolic action at white and brown adipose tissue

American Journal of Physiology - Endocrinology and Metabolism

Volumn 301, Issue 6, 2011, Pages

  de Kloet, Annette D ^a   Krause, Eric G ^b   Scott, Karen A ^c   Foster, Michelle T ^d   Herman, James P ^c,e   Sakai, Randall R ^c,e   Seeley, Randy J ^c,e   Woods, Stephen C ^c,e  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d Department of Environmental and Radiological Health Sciences   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Food intake; Obesity; Renin angiotensin system

Indexed keywords

ANGIOTENSIN II; BETA 3 ADRENERGIC RECEPTOR; CORTICOTROPIN; OXYGEN; PROOPIOMELANOCORTIN; THYROTROPIN; UNCOUPLING PROTEIN 1;

ANIMAL EXPERIMENT; ARTICLE; BODY TEMPERATURE; BROWN ADIPOSE TISSUE; CATABOLISM; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM FUNCTION; CONTROLLED STUDY; ENERGY BALANCE; ENERGY EXPENDITURE; FOOD INTAKE; MALE; NONHUMAN; OBESITY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYMPATHETIC FUNCTION; THERMOGENESIS; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; ANGIOTENSIN II; ANIMALS; BODY WEIGHT; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; EATING; INFUSION PUMPS, IMPLANTABLE; INFUSIONS, INTRAVENTRICULAR; INFUSIONS, SUBCUTANEOUS; MALE; METABOLISM; RATS; RATS, LONG-EVANS;

EID: 82355163616     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00307.2011     Document Type: Article

References (89)

1. Abuissa H, Jones PG, Marso SP, O'Keefe JH Jr. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 46: 821-826, 2005.
2. Aguilera G, Young WS, Kiss A, Bathia A. Direct regulation of hypothalamic corticotropin-releasing-hormone neurons by angiotensin II. Neuroendocrinology 61: 437-444, 1995.
3. Arruda AP, Milanski M, Romanatto T, Solon C, Coope A, Alberici LC, Festuccia WT, Hirabara SM, Ropelle E, Curi R, Carvalheira JB, Vercesi AE, Velloso LA. Hypothalamic actions of tumor necrosis factor alpha provide the thermogenic core for the wastage syndrome in cachexia. Endocrinology 151: 683-694, 2010.
4. Berne C. Metabolic effects of ACE inhibitors. J Intern Med Suppl 735: 119-125, 1991.
5. Bokil HS, Porter JP. Brain angiotensin type 1 receptor expression and function in the Zucker obese rat. Neurosci Lett 281: 139-142, 2000.
6. Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, Cassis LA. Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol 287: R943-R949, 2004.
7. Brito MN, Brito NA, Baro DJ, Song CK, Bartness TJ. Differential activation of the sympathetic innervation of adipose tissues by melanocortin receptor stimulation. Endocrinology 148: 5339-5347, 2007.
8. Burmeister MA, Young CN, Braga VA, Butler SD, Sharma RV, Davisson RL. In vivo bioluminescence imaging reveals redox-regulated activator protein-1 activation in paraventricular nucleus of mice with renovascular hypertension. Hypertension 57: 289-297, 2011.
9. Cassis L, Helton M, English V, Burke G. Angiotensin II regulates oxygen consumption. Am J Physiol Regul Integr Comp Physiol 282: R445-R453, 2002.
10. Cassis LA. Angiotensin II in brown adipose tissue from young and adult Zucker obese and lean rats. Am J Physiol Endocrinol Metab 266: E453-E458, 1994.
11. Cassis LA. Role of angiotensin II in brown adipose thermogenesis during cold acclimation. Am J Physiol Endocrinol Metab 265: E860-E865, 1993.
12. Cassis LA, Dwoskin LP. Presynaptic modulation of neurotransmitter release by endogenous angiotensin II in brown adipose tissue. J Neural Transm Suppl 34: 129-137, 1991.
13. Chen QH, Toney GM. Responses to GABA-A receptor blockade in the hypothalamic PVN are attenuated by local AT1 receptor antagonism. Am J Physiol Regul Integr Comp Physiol 285: R1231-R1239, 2003.
14. Cooper R, Forrester T, Ogunbiyi O, Muffinda J. Angiotensinogen levels and obesity in four black populations. ICSHIB Investigators. J Hypertens 16: 571-575, 1998.
15. Danielyan L, Lourhmati A, Verleysdonk S, Kabisch D, Proksch B, Thiess U, Umbreen S, Schmidt B, Gleiter CH. Angiotensin receptor type 1 blockade in astroglia decreases hypoxia-induced cell damage and TNF alpha release. Neurochem Res 32: 1489-1498, 2007.
16. de Kloet AD, Krause EG, Kim DH, Sakai RR, Seeley RJ, Woods SC. The effect of angiotensin-converting enzyme inhibition using captopril on energy balance and glucose homeostasis. Endocrinology 150: 4114-4123, 2009.
17. de Kloet AD, Krause EG, Woods SC. The renin angiotensin system and the metabolic syndrome. Physiol Behav 100: 525-534, 2010.
18. de Kloet AD, Pacheco-López G, Langhans W, Brown LM. The effect of TNFα on food intake and central insulin sensitivity in rats. Physiol Behav 103: 17-20, 2011.
19. Dewey AL, Wright JW, Hanesworth JM, Harding JW. Effects of aminopeptidase inhibition on the half-lives of [125I]angiotensins in the cerebroventricles of the rat. Brain Res 448: 369-372, 1988
20. Diraison F, Dusserre E, Vidal H, Sothier M, Beylot M. Increased hepatic lipogenesis but decreased expression of lipogenic gene in adipose tissue in human obesity. Am J Physiol Endocrinol Metab 282: E46-E51, 2002.
21. Dominguez JR, de la Calle H, Hurtado A, Robles RG, Sancho-Rof J. Effect of converting enzyme inhibitors in hypertensive patients with non-insulin-dependent diabetes mellitus. Postgrad Med J 62, Suppl 1: 66-68, 1986.
22. Dorward PK, Rudd CD. Influence of brain renin-angiotensin system on renal sympathetic and cardiac baroreflexes in conscious rabbits. Am J Physiol Heart Circ Physiol 260: H770-H778, 1991.
23. English V, Cassis L. Facilitation of sympathetic neurotransmission contributes to angiotensin regulation of body weight. J Neural Transm 106: 631-644, 1999.
24. Erdos B, Cudykier I, Woods M, Basgut B, Whidden M, Tawil R, Cardounel AJ, Tumer N. Hypertensive effects of central angiotensin II infusion and restraint stress are reduced with age. J Hypertens 28: 1298-1306, 2010.
25. Eriksson L, Fyhrquist F. Plasma renin activity following central infusion of angiotensin II and altered CSF sodium concentration in the conscious goat. Acta Physiol Scand 98: 209-216, 1976.
26. Even PC, Nicolaidis S. Adaptive changes in energy expenditure during mild and severe feed restriction in the rat. Br J Nutr 70: 421-431, 1993.
27. Ferguson AV. Angiotensinergic regulation of autonomic and neuroendocrine outputs: critical roles for the subfornical organ and paraventricular nucleus. Neuroendocrinology 89: 370-376, 2009.
28. Gordon RD, Kuchel O, Liddle GW, Island DP. Role of the sympathetic nervous system in regulating renin and aldosterone production in man. J Clin Invest 46: 599-605, 1967.
29. Grobe JL, Grobe CL, Beltz TG, Westphal SG, Morgan DA, Xu D, de Lange WJ, Li H, Sakai K, Thedens DR, Cassis LA, Rahmouni K, Mark AL, Johnson AK, Sigmund CD. The brain Renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance. Cell Metab 12: 431-442, 2010.
30. Hainault I, Nebout G, Turban S, Ardouin B, Ferré P, Quignard-Boulangé A. Adipose tissue-specific increase in angiotensinogen expression and secretion in the obese (fa/fa) Zucker rat. Am J Physiol Endocrinol Metab 282: E59-E66, 2002.
31. Herrmann HC, Dzau VJ. The feedback regulation of angiotensinogen production by components of the renin-angiotensin system. Circ Res 52: 328-334, 1983.
32. Hotta M, Shibasaki T, Arai K, Demura H. Corticotropin-releasing factor receptor type 1 mediates emotional stress-induced inhibition of food intake and behavioral changes in rats. Brain Res 823: 221-225, 1999.
33. Infanger DW, Cao X, Butler SD, Burmeister MA, Zhou Y, Stupinski JA, Sharma RV, Davisson RL. Silencing nox4 in the paraventricular nucleus improves myocardial infarction-induced cardiac dysfunction by attenuating sympathoexcitation and periinfarct apoptosis. Circ Res 106: 1763-1774, 2010.
34. Jaillard T, Roger M, Galinier A, Guillou P, Benani A, Leloup C, Casteilla L, Penicaud L, Lorsignol A. Hypothalamic reactive oxygen species are required for insulin-induced food intake inhibition: an NADPH oxidase-dependent mechanism. Diabetes 58: 1544-1549, 2009.
35. Jiang L, Wang Q, Yu Y, Zhao F, Huang P, Zeng R, Qi RZ, Li W, Liu Y. Leptin contributes to the adaptive responses of mice to high-fat diet intake through suppressing the lipogenic pathway. PLoS One 4: e6884, 2009.
36. Jones BH, Standridge MK, Moustaid N. Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells. Endocrinology 138: 1512-1519, 1997.
37. Kannan H, Nakamura T, Jin XJ, Hayashida Y, Yamashita H. Effects of centrally administered angiotensin on sympathetic nerve activity and blood flow to the kidney in conscious rats. J Auton Nerv Syst 34: 201-210, 1991.
38. Kasper SO, Carter CS, Ferrario CM, Ganten D, Ferder LF, Sonntag WE, Gallagher PE, Diz DI. Growth, metabolism, and blood pressure disturbances during aging in transgenic rats with altered brain reninangiotensin systems. Physiol Genomics 23: 311-317, 2005.
39. King AJ, Osborn JW, Fink GD. Splanchnic circulation is a critical neural target in angiotensin II salt hypertension in rats. Hypertension 50: 547-556, 2007.
40. Kow LM, Pfaff DW. The effects of the TRH metabolite cyclo(His-Pro) and its analogs on feeding. Pharmacol Biochem Behav 38: 359-364, 1991.
41. Krahn DD, Gosnell BA, Grace M, Levine AS. CRF antagonist partially reverses CRF-and stress-induced effects on feeding. Brain Res Bull 17: 285-289, 1986.
42. Krause EG, Melhorn SJ, Davis JF, Scott KA, Ma LY, de Kloet AD, Benoit SC, Woods SC, Sakai RR. Angiotensin type 1 receptors in the subfornical organ mediate the drinking and hypothalamic-pituitary-adrenal response to systemic isoproterenol. Endocrinology 149: 6416-6424, 2008.
43. Kumar MV, Moore RL, Scarpace PJ. Beta3-adrenergic regulation of leptin, food intake, and adiposity is impaired with age. Pflugers Arch 438: 681-688, 1999.
44. Langhans W, Delprete E, Scharrer E. Mechanisms of vasopressin's anorectic effect. Physiol Behav 49: 169-176, 1991.
45. Lenkei Z, Palkovits M, Corvol P, Llorens-Cortès C. Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front Neuroendocrinol 18: 383-439, 1997.
46. Li DP, Chen SR, Pan HL. Angiotensin II stimulates spinally projecting paraventricular neurons through presynaptic disinhibition. J Neurosci 23: 5041-5049, 2003.
47. Li DP, Pan HL. Angiotensin II attenuates synaptic GABA release and excites paraventricular-rostral ventrolateral medulla output neurons. J Pharmacol Exp Ther 313: 1035-1045, 2005.
48. Li H, Gao Y, Qi Y, Katovich MJ, Jiang N, Braseth LN, Scheuer DA, Shi P, Sumners C. Macrophage migration inhibitory factor in hypothalamic paraventricular nucleus neurons decreases blood pressure in spontaneously hypertensive rats. FASEB J 22: 3175-3185, 2008.
49. Li Z, Ferguson AV. Subfornical organ efferents to paraventricular nucleus utilize angiotensin as a neurotransmitter. Am J Physiol Regul Integr Comp Physiol 265: R302-R309, 1993.
50. Lin MT, Chandra A, Jou JJ. Angiotensin II inhibits both heat production and heat loss mechanisms in the rat. Can J Physiol Pharmacol 58: 909-914, 1980.
51. Madden CJ, Morrison SF. Neurons in the paraventricular nucleus of the hypothalamus inhibit sympathetic outflow to brown adipose tissue. Am J Physiol Regul Integr Comp Physiol 296: R831-R843, 2009.
52. Malayan SA, Keil LC, Ramsay DJ, Reid IA. Mechanism of suppression of plasma renin activity by centrally administered angiotensin II. Endocrinology 104: 672-675, 1979.
53. Massiéra F, Bloch-Faure M, Ceiler D, Murakami K, Fukamizu A, Gasc JM, Quignard-Boulange A, Negrel R, Ailhaud G, Seydoux J, Meneton P, Teboul M. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J 15: 2727-2729, 2001.
54. May CN, McAllen RM. Baroreceptor-independent renal nerve inhibition by intracerebroventricular angiotensin II in conscious sheep. Am J Physiol Regul Integr Comp Physiol 273: R560-R567, 1997.
55. McKinley MJ, McBurnie MI, Mathai ML. Neural mechanisms subserving central angiotensinergic influences on plasma renin in sheep. Hypertension 37: 1375-1381, 2001.
56. Meyer JM, Felten DL, Weyhenmeyer JA. Measurement of immunoreactive angiotensin II levels in microdissected brain nuclei from developing spontaneously hypertensive and Wistar Kyoto rats. Exp Neurol 107: 164-169, 1990.
57. Niklason A, Hedner T, Niskanen L, Lanke J; Captopril Prevention Project Study Group. Development of diabetes is retarded by ACE inhibition in hypertensive patients-a subanalysis of the Captopril Prevention Project (CAPPP). J Hypertens 22: 645-652, 2004.
58. Olson BR, Drutarosky MD, Stricker EM, Verbalis JG. Brain oxytocin receptor antagonism blunts the effects of anorexigenic treatments in rats: evidence for central oxytocin inhibition of food intake. Endocrinology 129: 785-791, 1991.
59. Ortega FJ, Mayas D, Moreno-Navarrete JM, Catalán V, Gómez-Ambrosi J, Esteve E, Rodriguez-Hermosa JI, Ruiz B, Ricart W, Peral B, Fruhbeck G, Tinahones FJ, Fernández-Real JM. The gene expression of the main lipogenic enzymes is downregulated in visceral adipose tissue of obese subjects. Obesity (Silver Spring) 18: 13-20, 2010.
60. Osborn JW, Fink GD. Region-specific changes in sympathetic nerve activity in angiotensin II-salt hypertension in the rat. Exp Physiol 95: 61-68, 2010.
61. Osborn JW, Fink GD, Kuroki MT. Neural mechanisms of angiotensin II-salt hypertension: implications for therapies targeting neural control of the splanchnic circulation. Curr Hypertens Rep 13: 221-228, 2011
62. Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 86: 747-803, 2006.
63. Peterson JR, Burmeister MA, Tian X, Zhou Y, Guruju MR, Stupinski JA, Sharma RV, Davisson RL. Genetic silencing of Nox2 and Nox4 reveals differential roles of these NADPH oxidase homologues in the vasopressor and dipsogenic effects of brain angiotensin II. Hypertension 54: 1106-1114, 2009.
64. Porter JP, Anderson JM, Robison RJ, Phillips AC. Effect of central angiotensin II on body weight gain in young rats. Brain Res 959: 20-28, 2003.
65. Porter JP, Potratz KR. Effect of intracerebroventricular angiotensin II on body weight and food intake in adult rats. Am J Physiol Regul Integr Comp Physiol 287: R422-R428, 2004.
66. Rahmouni K, Mark AL, Haynes WG, Sigmund CD. Adipose depotspecific modulation of angiotensinogen gene expression in diet-induced obesity. Am J Physiol Endocrinol Metab 286: E891-E895, 2004.
67. Richard D, Lin Q, Timofeeva E. The corticotropin-releasing factor family of peptides and CRF receptors: their roles in the regulation of energy balance. Eur J Pharmacol 440: 189-197, 2002.
68. Ruano M, Silvestre V, Castro R, García-Lescún MC, Rodríguez A, Marco A, García-Blanch G. Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis. Obes Surg 15: 670-676, 2005.
69. Sarruf DA, Thaler JP, Morton GJ, German J, Fischer JD, Ogimoto K, Schwartz MW. Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats. Diabetes 59: 1817-1824, 2010.
70. Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM. Renin-angiotensin system and cardiovascular risk. Lancet 369: 1208-1219, 2007.
71. Schuhler S, Warner A, Finney N, Bennett GW, Ebling FJ, Brameld JM. Thyrotrophin-releasing hormone decreases feeding and increases body temperature, activity and oxygen consumption in Siberian hamsters. J Neuroendocrinol 19: 239-249, 2007.
72. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 404: 661-671, 2000.
73. Seltzer A, Tsutsumi K, Shigematsu K, Saavedra JM. Reproductive hormones modulate angiotensin II AT1 receptors in the dorsomedial arcuate nucleus of the female rat. Endocrinology 133: 939-941, 1993.
74. Shi P, Diez-Freire C, Jun JY, Qi Y, Katovich MJ, Li Q, Sriramula S, Francis J, Sumners C, Raizada MK. Brain microglial cytokines in neurogenic hypertension. Hypertension 56: 297-303, 2010.
75. Shido O, Nagasaka T. Effects of intraventricular angiotensin II on heat balance at various ambient temperatures in rats. Jpn J Physiol 35: 163-167, 1985.
76. Shimabukuro M, Tanaka H, Shimabukuro T. Effects of telmisartan on fat distribution in individuals with the metabolic syndrome. J Hypertens 25: 841-848, 2007.
77. Smith PM, Chambers AP, Price CJ, Ho W, Hopf C, Sharkey KA, Ferguson AV. The subfornical organ: a central nervous system site for actions of circulating leptin. Am J Physiol Regul Integr Comp Physiol 296: R512-R520, 2009.
78. Smith PM, Rozanski G, Ferguson AV. Acute electrical stimulation of the subfornical organ induces feeding in satiated rats. Physiol Behav 99: 534-537, 2010.
79. Sumitomo T, Suda T, Nakano Y, Tozawa F, Yamada M, Demura H. Angiotensin II increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus. Endocrinology 128: 2248-2252, 1991.
80. Taicher GZ, Tinsley FC, Reiderman A, Heiman ML. Quantitative magnetic resonance (QMR) method for bone and whole-body-composition analysis. Anal Bioanal Chem 377: 990-1002, 2003.
81. Toney GM, Pedrino GR, Fink GD, Osborn JW. Does enhanced respiratory-sympathetic coupling contribute to peripheral neural mechanisms of angiotensin II-salt hypertension? Exp Physiol 95: 587-594, 2010.
82. Ulrich-Lai YM, Engeland WC. Adrenal splanchnic innervation modulates adrenal cortical responses to dehydration stress in rats. Neuroendocrinology 76: 79-92, 2002.
83. Velloso LA, Folli F, Sun XJ, White MF, Saad MJ, Kahn CR. Cross-talk between the insulin and angiotensin signaling systems. Proc Natl Acad Sci USA 93: 12490-12495, 1996.
84. Weisinger HS, Begg DP, Egan GF, Jayasooriya AP, Lie F, Mathai ML, Sinclair AJ, Wark JD, Weisinger RS. Angiotensin converting enzyme inhibition from birth reduces body weight and body fat in Sprague-Dawley rats. Physiol Behav 93: 820-825, 2008.
85. Weisinger RS, Stanley TK, Begg DP, Weisinger HS, Spark KJ, Jois M. Angiotensin converting enzyme inhibition lowers body weight and improves glucose tolerance in C57BL/6J mice maintained on a high fat diet. Physiol Behav 98: 192-197, 2009.
86. Welle SL, Thompson DA, Campbell RG. β-Adrenergic blockade inhibits thermogenesis and lipolysis during glucoprivation in humans. Am J Physiol Regul Integr Comp Physiol 243: R379-R382, 1982.
87. Wilkinson CW, Shinsako J, Dallman MF. Rapid decreases in adrenal and plasma corticosterone concentrations after drinking are not mediated by changes in plasma adrenocorticotropin concentration. Endocrinology 110: 1599-1606, 1982.
88. Woods SC, Seeley RJ, Porte D Jr, Schwartz MW. Signals that regulate food intake and energy homeostasis. Science 280: 1378-1383, 1998.
89. Yoshimoto M, Miki K, Fink GD, King A, Osborn JW. Chronic angiotensin II infusion causes differential responses in regional sympathetic nerve activity in rats. Hypertension 55: 644-651, 2010